Xtrenbo

Denosumab-qbde · Hikma Pharmaceuticals USA Inc.
PRESCRIPTION ONLY (USA)

Xtrenbo ingredients

Active ingredientStrength
Denosumab120 mg/1.7mL

What Xtrenbo is used for

Xtrenbo is a specialist medicine (rank ligand inhibitor). Its approved uses are listed on the official FDA label below.

Key facts

Brand
Xtrenbo
Generic name
Denosumab-qbde
Made by
Hikma Pharmaceuticals USA Inc.
Forms
Injection
Given
Subcutaneous
Drug class
RANK Ligand Inhibitor
FDA approval
Biologic licence (BLA) BLA761439
On the US market since
2026

Official information

In India

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Xtrenbo?

Xtrenbo (Denosumab-qbde) is a specialist medicine made by Hikma Pharmaceuticals USA Inc., approved by the US FDA.

What are the ingredients of Xtrenbo?

Xtrenbo contains Denosumab (120 mg/1.7mL).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.